An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: Correlation with the presence of myocardial Trypanosoma cruzi antigens

Clinical Immunology and Immunopathology

Volumn 83, Issue 2, 1997, Pages 165-172

  Reis, Marcia Martins ^a   Higuchi, Maria De Lourdes ^a   Benvenuti, Luiz Alberto ^a   Aiello, Vera Demarchi ^a   Gutierrez, Paulo Sampaio ^a   Bellotti, Giovanni ^a   Pileggi, Fulvio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; B LYMPHOCYTE; CHAGAS DISEASE; CLINICAL ARTICLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOCARDITIS; PRIORITY JOURNAL; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

EID: 0343145700     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4335     Document Type: Article

References (47)

1. WHO Technical Report Series. 1991;69-77.
2. Dias J. C. P. Control of Chagas disease in Brazil. Parasitol. Today. 3:1987;336-341.
3. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. T lymphocyte fuction during experimental Chagas' disease: Production of and response to interleukin 2. Eur. J. Immunol. 15:1985;438-442.
4. Molina H. A., Kierszenbaum F. A study of human myocardial tissue in Chagas' disease: A distribution and frequency of inflammatory cell types. Int. J. Parasitol. 17:1987;1297-1306.
5. Rossi M. A. Myocardial damage inTrypanosoma cruzi. Can. J. Cardiol. 6:1990;293-298.
6. Cunha-Neto E., Duranti M., Gruber A., Zingales B., De Messias I., Stolf N., Bellotti G., Pilleggi F., Kalil J. Autoimmunity in Chagas' disease cardiopathy: Biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominantTrypanosoma cruzi. Proc. Natl. Acad. Sci. USA. 92:1995;3541-3545.
7. Cossio P. M., Diez D., Szarfman A., Arana R. M. Chagasic cardiopathy: Demonstration of a serum gamma factor globulin factor which reacts with endocardium and vascular structures. Circulation. 49:1974;13-21.
8. Santos-Buch C. A., Teixeira A. R. L. Immunology of experimental Chagas' disease. III. Rejection of allogeneic heart cells in vitro. J. Exp. Med. 140:1988;398-402.
9. Higuchi M. L., Moraes C. F., Pereira-Barreto A. C., Lopes E. A., Bellotti G., Pileggi F. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: A study bases on endomyocardial biopsies. Clin Cardiol. 10:1987;665-670.
10. Higuchi M. L., Gutierrez P. S., Aiello V. D., Palomino S., Bochi E., Kalil J., Bellotti G., Pileggi F. Immunohistochemical caracterization of infiltrating cells in human chronic chagasic myocarditis: Comparison with myocardial rejection process. Virchows Arch. A. Pathol. Anat. 423:1993;157-160.
11. Jones E. M., Colley D. G., Tostes S. J., Lopes E. R., Vnencak-Jones C. L., McCurley T. L. Amplification ofTrypanosoma cruzi. Am. J. Trop. Med. Hyg. 48:1993;348-357.
12. Sher A., Gazzinelli R. T., Oswald I. P., Clerici M., Kullberg M., Pearce E. J., Berzosfsky J. A., Mosmann T. R., James S. L., Morse H. C. III, Shearer G. M. Role of T cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:1992;183-204.
13. Hayes M. M., Kierszenbaum F. Experimental Chagas' disease: Kinetics of lymphocyte responses and immunologic control of the transition from acute to chronicTrypanosoma cruzi. Infect. Immun. 31:1981;1117-1124.
14. Beltz L. A., Sztein M. B., Kierszenbaum F. Novel mechanism forTrypanosoma cruzi. J. Immunol. 141:1988;289-294.
15. Kierszenbaum F. Trypanosomal immunosuppressive factor: A secretion product(s) ofTrypanosoma cruzi. J. Immunol. 144:1990;4000-4004.
16. Nabors G. S., Tarleton R. L. Differential control of IFN-γ and IL-2 production duringT. cruzi. J. Immunol. 146:1991;3591-3597.
17. Kierszenbaum F., Sztein M. B. Trypanosoma cruzi. Immunology. 75:1992;546-549.
18. Tanowitz H. B., Kirchhoff L. V., Simon D., Mouris S. A., Weiss L. M., Wittner M. Chagas' disease. Clin. Microbiol. Rev. 5:1992;400-419.
19. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
20. Ben Younès-Chennoufi A., Hontebeyrie-Joskowicz M., Tricottet V., Eisen H., Reynes M., Said G. Persistence ofTrypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 82:1988;77-83.
21. Higuchi M. L., Brito T., Reis M. M., Barbosa A., Bellotti G., Pereira-Barreto A. C., Pileggi F. Correlation betweenTrypanosoma cruzi. Cardiovasc. Pathol. 2:1993;101-106.
22. Reis D. A., Jones E. M., Tostes S. Jr., Lopes E. R., Gazzinelli G., Colley D. G., McCurley T. L. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: Presence of tumor necrosis factor-α+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 48:1993;637-644.
23. Sato M. M., Yamashiro-Kanashiro E. H., Tanji M. M., Kaneno R., Higuchi M. L., Duarte J. S. CD8+ cells and natural cytotoxic activity among spleen, blood, and heart lymphocytes during the acute phase ofTrypanosoma cruzi. Infect. Immun. 60:1992;1024-1030.
24. Tarleton R. L. Trypanosoma cruzi. J. Immunol. 140:1988;2763-2768.
25. Tarleton R. L. Trypanosoma cruzi. J. Immunol. 140:1988;2769-2773.
26. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A. E., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokines activities and secretes proteins. J. Immunol. 136:1986;2348-2352.
27. Mosmann T. R., Schumacher J. H., Street N. F., Budd R., O'Garra A., Fong T. A. T., Bond M. W., Moore K. W. M., Sher A., Fiorentino D. F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 123:1991;209-229.
28. Sadick M. D., Locksley R. M., Tubbs C., Raff H. V. Murine cutaneous leishmaniasis: Resistance correlates with the capacity to generate inferferon-γ in response toLeishmania. J. Immunol. 136:1986;655-661.
29. Sadick M. D., Heinzel F. P., Shigekane V. M., Fisher W. L., Locksley R. M. Cellular and humoral immunity toLeishmania major. J. Immunol. 139:1987;1303-1309.
30. Titus R. G., Kelso A., Louis J. A. Intracellular destruction ofLeishmania tropica. Clin. Exp. Immunol. 55:1984;157-165.
31. Titus R. G., Sherry B., Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:1989;2097-2104.
32. Kemeny D. M., Noble A., Holmes B. J., Dias-Sanchez D. Immune regulation: A new role for the CD8+ T cell. Immunol. Today. 15:1994;107-110.
33. Locksley M. R. E., Scott P. Helper T cell subsets in mouse leishmaniasis: Induction, expansion and effector function. Immunol. Today. 10:1991;A58-A61.
34. Sadick M. D., Heinzel F. P., Holaday B. J., Pu R. T., Dawkins R. S., Locksley R. M. Cure of murine Leishmaniasis with anti-IL4 monoclonal antibody: Evidence for a T cell-dependent, Interferon γ-independent mechanism. J. Exp. Med. 171:1990;115-127.
35. Abramson S. L., Gallin J. I. IL-4 Inhibits superoxido production by human mononuclear phagocytes. J. Immunol. 144:1990;625-630.
36. Golden J. M., Tarleton R. L. Trypanosoma cruzi: Exp. Parasitol. 72:1991;391-402.
37. Gazzinelli R. T., Oswald I. P., James S. L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages againstTrypanosoma cruzi. Eur. J. Immunol. 22:1992;2501-2506.
38. Abbas A. K., Lichtman A. H., Pober J. S. Cellular and molecular immunology. Effector Mechanisms of Immunoglobulin E - initiated Immune Reactions. 1994;Saunders, Philadelphia. p. 279-292.
39. Esparza I., Mannel D., Ruppel A., Falk W., Krammer P. H. Interferon-γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni. J. Exp. Med. 166:1987;589-594.
40. Muñoz-Fernández M. A., Fernandez M. A., Fresmo M. Synergism between tumor necrosis factor-a on macrophages activation for the killing of intracellularTrypanosoma cruzi. Eur. J. Immunol. 22:1992;301-307.
41. Wirth J. J., Kierszenbaum F. Recombinant tumor necrosis factor enhances macrophage destruction ofTrypanosoma cruzi. J. Immunol. 141:1988;286-288.
42. Titus R. G., Sherry B., Cerami A., The involvement of TNF Il-. 1 and IL-6 in the immune response to protozoan parasites. Immunol. Today. 12:1991;A13-A16.
43. Jörg M. E., Castagnino H. E., Storino R. A., Sapino R. V., Bessola T. Tripamosomiasis Americana (enfermedad de Chagas) y factor de necrosis tumoral alfa. Comprobación inicial sobre possible correlation con la cardiopatia parasitária. CMPM. 7:1994;43-53.
44. Beutler F. R., Cerami A. The biology of cachectin-TNF-α primary mediator of the host response. Annu. Rev. Immunol. 7:1988;625-655.
45. May M. J., Ager A. ICAM-1-independent lymphocyte across high endothelium: differential up-regulation by interferon-γ, tumor necrosis factor-a and interleukin-1b. Eur. J. Immunol. 22:1992;219-226.
46. Tanowitz H. B., Gumprecht J. P., Spurr D., Calderon T. M., Ventura M. C., Raventos-Soarez C., Kellie S., Factor S. M., Hatcher V. B., Wittner M., Berman J. W. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J. Infect. Dis. 166:1992;598-603.
47. Calandra T., Gerain J., Heumann D., Baumgartner J. D., Glauser M. P. High circulating leves of IL-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 91:1991;23-29.